Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen

被引:61
作者
Xu, C
Politch, JA
Tucker, L
Mayer, KH
Seage, GR
Anderson, DJ
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT OBSTET GYNECOL & REPROD BIOL,FEARING RES LAB,BOSTON,MA 02115
[2] BOSTON DEPT HLTH & HOSP,INST URBAN HLTH RES,FENWAY COMMUNITY HLTH CTR,BOSTON,MA
[3] BOSTON UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL & BIOSTAT,BOSTON,MA
[4] BROWN UNIV,AIDS PROGRAM,PROVIDENCE,RI 02912
[5] MEM HOSP,DIV INFECT DIS,PAWTUCKET,RI 02860
关键词
D O I
10.1086/516539
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1)-infected cells have been isolated from semen and may be a major source of transmissible virus. Quantitative polymerase chain reaction (PCR) assay was used to determine HIV proviral DNA load in cellular fractions of semen from 74 antiviral therapy-naive HIV-1-seropositive men and 53 paired blood samples, HIV-1 DNA was detected in 65% of semen (range: <10-5000 copies/ml) and 100% of blood samples (range: 20-2500 copies/ mL). HIV-1 DNA copy numbers in semen correlated significantly with those in blood, but for most cases, the concentration of blood HIV-1 DNA was higher (mean blood-to-semen ratio = 2.9), Factors associated with elevated HIV-1 provirus levels in semen included reduced peripheral CD4 cell count and asymptomatic genital tract inflammation (>10(6) white blood cells/mL of semen). These data provide evidence that genital tract inflammation and reduced peripheral CD4 cell count may be associated with enhanced sexual transmission of HIV-1 because of increased numbers of HIV-1-infected cells in semen.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 30 条
[1]   EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN [J].
ANDERSON, DJ ;
OBRIEN, TR ;
POLITCH, JA ;
MARTINEZ, A ;
SEAGE, GR ;
PADIAN, N ;
HORSBURGH, CR ;
MAYER, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2769-2774
[2]   QUANTITATIVE-ANALYSIS OF HIV-1 PROVIRAL DNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH AIDS OR ARC - DECREASE OF PROVIRAL DNA CONTENT FOLLOWING TREATMENT WITH 2',3'-DIDEOXYINOSINE (DDI) [J].
AOKI, S ;
YARCHOAN, R ;
THOMAS, RV ;
PLUDA, JM ;
MARCZYK, K ;
BRODER, S ;
MITSUYA, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) :1331-1339
[3]  
BOURINBAIAR AS, 1991, J ACQ IMMUN DEF SYND, V4, P56
[4]  
ENDTZ AW, 1974, ACTA CYTOL, V18, P2
[5]   RELEVANCE OF THE QUANTITATIVE DETECTION OF HIV PROVIRAL SEQUENCES IN PBMC OF INFECTED INDIVIDUALS [J].
ESCAICH, S ;
RITTER, J ;
ROUGIER, P ;
LEPOT, D ;
LAMELIN, JP ;
SEPETJAN, M ;
TREPO, C .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) :1833-1837
[6]   QUANTITATION OF HIV VIRAL BURDEN BY PCR IN HIV SEROPOSITIVE NAVY PERSONNEL REPRESENTING WALTER REED STAGES 1 TO 6 [J].
FERRE, F ;
MARCHESE, A ;
DUFFY, PC ;
LEWIS, DE ;
WALLACE, MR ;
BEECHAM, HJ ;
BURNETT, KG ;
JENSEN, FC ;
CARLO, DJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :269-275
[7]   BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A CLONED LEU-3- CELL SURVIVING INFECTION WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME RETROVIRUS [J].
FOLKS, TM ;
POWELL, D ;
LIGHTFOOTE, M ;
KOENIG, S ;
FAUCI, AS ;
BENN, S ;
RABSON, A ;
DAUGHERTY, D ;
GENDELMAN, HE ;
HOGGAN, MD ;
VENKATESAN, S ;
MARTIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :280-290
[8]  
GIRARD M, 1993, P 8 C CENT GARD RETR, P139
[9]  
GIUSTI A, 1986, J FORENSIC SCI, V31, P409
[10]   DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN - EFFECTS OF DISEASE STAGE AND NUCLEOSIDE THERAPY [J].
HAMED, KA ;
WINTERS, MA ;
HOLODNIY, M ;
KATZENSTEIN, DA ;
MERIGAN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) :798-802